Long Term Prognosis in IgG4-related Systemic Disease (ISD)

Current Immunology Reviews

Volumn 7, Issue 2, 2011, Pages 239-245

  Sah, Raghuwansh P ^a   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune pancreatitis; IgG4 related systemic disease; Lymphoplasmacytic sclerosing pancreatitis

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G4; MYCOPHENOLIC ACID;

ARTICLE; AUTOIMMUNE PANCREATITIS; ENTERITIS; INTERSTITIAL NEPHRITIS; PANCREAS EXOCRINE INSUFFICIENCY; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; SCLEROSING CHOLANGITIS; STEATORRHEA;

EID: 79953885844     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339511795194848     Document Type: Article

References (98)

1. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27: 1-13.
2. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin N Am 2008; 37: 439-60.
3. Otsuki M, Chung JB, Okazaki K, et al. Asian Diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008; 43: 403-8.
4. Pannala R, Chari ST. Autoimmune pancreatitis. Curr Opin Gastroenterol 2008; 24: 591-6.
5. Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 2007; 42(Suppl 18): 15-21.
6. Naitoh I, Nakazawa T, Ohara H, et al. Clinical significance of extrapancreatic lesions in autoimmine pancreatitis. Pancreas 2010; 39(1): e1-5.
7. Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-205.
8. Kamisawa T, Egawa N, Nakajima H, et al. Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 2005; 39: 904-7.
9. Nishimori I, Suda K, Oi I, Ogawa M. Autoimmune pancreatitis [in Japanese with English abstract]. Nippon Shokakibyo Gakkai Zasshi 2000; 97: 1355-63.
10. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas 2004; 29: 167-8.
11. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20: 23-8.
12. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of Diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445: 552-63.
13. Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic Sclerosing Pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol 2004; 28: 1114.
14. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006; 30: 1537-45.
15. Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6: 132-7.
16. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14(25): 3948-55.
17. Ghazale A, Chari ST, Zhang Lizhi, et al. Immunoglobulin G4-associated cholangitis: Clinical Profile and response to steroids. Gastroenterology 2008; 134: 760-15.
18. Bjornsson E, Chari ST, Smyrk TC, et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007; 45(6): 1547-54.
19. Hirano K, Shiratori Y, Komatsu Y, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003; 1: 453-64.
20. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30: 20-5.
21. Yamamoto N, Fletcher JG, Fidler JL, et al. Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi 2008; 31: 1-8.
22. Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology 2005; 44: 227-34.
23. Kubota K, Wada T, Kato S, et al. Highly active state of autoimmune pancreatitis with mikulicz disease. Pancreas 2010; 39(1): e6-10.
24. Kamisawa T, Takuma K, Kuruma S, et al. Lacrimal gland function in autoimmune pancreatitis. Inter Med 2009; 48: 939-43.
25. Takahashi N, Kawashima A, Fletcher JG, et al. Renal Involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007; 242: 791-801.
26. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune complex tubulointerstitial nephritis associated with autoimmune pancreatitocentric disease. Am J Surg Pathol 2007; 31: 1586-97.
27. Saeki T, Nishi S, Ito T, et al. Renal lesions in IgG4-related systemic disease. Intern Med 2007; 46(17): 1365-71.
28. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol 2006; 30: 1472-7.
29. Rudmik L, Trpkov K, Nash C, et al. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ 2006; 175(4): 367-9.
30. Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kid Dis 2004; 43: e18-25.
31. Takeda S, Haratake J, Kasai T, Takeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004; 19: 474-6.
32. Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359(9315): 1403-4.
33. Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP 2005; 10: 260-3.
34. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, riedel's thyroiditis and pseudotumor of the orbit may be different manifestations of a single disease. Amm Intern Med 1967; 66: 884-92.
35. Bartholomew LG, Cain JC, Woolner LB. Sclerosing cholangitis. Its possible association with Riedel's struma and fibrous retroperitonitis. New Engl J Med 1963; 269: 8-12.
36. Komatsu K, Hamano H, Ocho Y, et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 2005; 50: 1052-57.
37. Sah RP, Chari ST. Clinical hypothyroidism in Autoimmune Pancreatitis. Pancreas 2010; 39(7): 114-6.
38. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463-71.
39. Chung H, Watanabe T, Kudo M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int 2010; 30(2): 222-31.
40. Taniguchi T, Ko M, Seko S, et al. Interstitial pneumonia associated with autoimmune pancreatitis. Gut 2004; 53: 770.
41. Kobayashi H, Shimokawaji T, Kanoh S, Motoyoshi K, Aida S. IgG4-positive pulmonary disease. J Thorac Imaging 2007; 22: 360-2.
42. Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47: 291-4.
43. Hirano K, Kawabe T, Komatsu Y, et al. High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 2006; 36(1): 58-61.
44. Sasahira N, Kawabe T, Nakamura A, et al. Inflammatory pseudotumor of the liver and peripheral eosinophilia in autoimmune pancreatitis. World J Gastroenterol 2005; 11: 922-5.
45. Van der Vliet HJ, Perenboom RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 2004; 141: 896-7.
46. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis associated sclerosing cholangitis. Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
47. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36: 710-7.
48. Uchida K, Satoi S, Miyoshi H, et al. Inflammatory pseudotumors of the pancreas and liver with infiltration of IgG4-positive plasma cells. Intern Med 2007; 46: 1409-12.
49. Yoshimura Y, Takeda S, Ieki Y, Takazakura E, Koizumi H, Takagawa K. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 2006; 45: 897-901.
50. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 2007; 46: 1983-9.
51. Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis associated prostatitis: distinct clinicopathological entity. Pathol Int 2008; 58: 118-25.
52. Nayar M, Charnley R, Scott J, et al. Autoimmune pancreatitis with multiorgan involvement: a case of pericardial involvement. J Pancreas (Online) 2009; 10(5): 539-42.
53. Shinji A, Sano K, Hamano H, et al. Autoimmune pancreatitis is closely associated with gastric ulcer presenting with abundant IgG4-bearing plasma cell infiltration. Gastrointest Endosc 2004; 59(4): 506-11.
54. Chang MC, Chang YT, Wei SC. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status. Pancreas 2009; 38(4): 442-6.
55. Kaji R, Okabe Y, Ishida Y, et al. Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps. Gastrointest Endosc 2010; 71(2): 420-2
56. Matsui H, Watanabe T, Ueno S, et al. Colonic polyposis associated with autoimmune pancreatitis. Pancreas 2009; 38(7): 840-2.
57. Tabata R, Tabata C, Okamoto T, et al. Autoimmune pancreatitis associated with myelodysplastic syndrome. Int Arch Allergy Immunol 2009; 151(2): 168-72.
58. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4 positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68: 1310-5.
59. Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 2009; 38: 523-6.
60. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005; 5: 234-8.
61. Hirano K, Tada M, Isayama H, et al. Long term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007; 56: 1719-24
62. Ito T, Nishimori I, Inoue N, et al. Treatment of autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007; 42(Suppl XVIII): 50-8.
63. Ghazale A, Chari S. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007; 56: 1650-2.
64. Kamisawa T, Shimosegawa T, Okazaki, et al. Standard steroid therapy for autoimmune pancreatitis. Gut 2009; 58: 1504-7.
65. Pannala R, Chari ST. Corticosteroid treatment for autoimmune pancreatitis. Gut 2009; 58 (11): 1438-9.
66. Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroid therapy for autoimmune pancreatitis based on long term outcome. Scand J Gastroenterol 2008; 43: 609-13.
67. Nishino T, Toki F, Oyama H, et al. Long term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45: 497-501.
68. Wakabayashi T, Kawaura Y, Satomura Y, et al. Long term prognosis of duct narrowing chronic pancreatitis. Strategy for steroid treatment. Pancreas 2005; 30: 31-9.
69. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: Clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102: 2417-25.
70. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastroent Endosc 2007; 66: 1142-51.
71. Kamisawa T, Atsutake O. Prognosis of autoimmune pancreatitits. J Gastroenterol 2007; 42(Suppl XVIII): 59-62.
72. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009; 104(9): 2295-306.
73. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/Immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7(10): 1089-96.
74. Ryu KJ, Chung JB, Park SW, et al. Review of 67 patients with Autoimmune pancreatitis in Korea-a multicenter nationwide study. Pancreas 2008; 37 (4): 377-85.
75. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009; 104(9): 2288-94.
76. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99: 932-7.
77. Weber SM, Dimopulo OC, Palesty A, et al. Lymphoplasmacytic sclersing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7: 129-39.
78. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134: 440-6.
79. Chari ST. Autoimmune pancreatitis, part II: the relapse. Gastroenterology 2008; 134: 625-8.
80. Hirano K, Asaoka Y, Tada M, et al. No significant relation between relapse of atoimmune pancreatitis and substitution of aspartic acid at position 57 of DQ_1. J Gastroenterol 2009; 44(7): 799-800.
81. Kim KP, Kim MH, Dong MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99: 1605-16.
82. Uchida K, Yazumi S, Nishio A, et al. Long term outcome of autoimmune pancreatitis. J Gastroenterol 2009; 44(7): 726-32.
83. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroidresponse diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann N Y Acad Sci 2002; 958: 152-9.
84. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34: 254-9.
85. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003; 27: 235-8.
86. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis. Findings from a nationwide survey in Japan. Pancreas 2006; 32: 244-8.
87. Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis and profile of Autoimmune pancreatitis with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010; 8(1): 91-6.
88. Ravi K, Chari ST, Vege SS, et al. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 2009; 15(9): 1326-30.
89. Kamisawa T, Anjiki H, Egawa N, et al. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1136-9.
90. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003; 348(26): 2646-55.
91. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long term maintenance of remission in autoimmune hepatitis. N Eng J Med 1995; 333: 958-63.
92. Park DH, Kim MH, Chari ST. Recent Advances in autoimmune pancreatitis. Gut 2009; 58(12): 1680-9.
93. Topazian M, Witzig TE, Smyrc TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gaastroenterol Hepatol 2008; 6: 364-6.
94. Ghazale A, Chari ST. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas 2007; 35(4): 376.
95. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33: 208-9.
96. Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med 2008; 47: 151-5.
97. Motosui U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int 2009; 59(10): 744-7.
98. Kamisawa T, Tsuruta K, Okamoto A, et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas 2009; 38(8): 890-5.